SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. , a biopharmaceutical company focused on the development and commercialization of recombinant human enzymes, today announced that the Company will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference to be held November 7-9, 2005 at the New York Palace Hotel in New York City.
Jonathan E. Lim, MD, Halozyme's Chairman and Chief Executive Officer, is scheduled to speak on Tuesday, November 8, 2005 at 9:25 AM Eastern Time and will discuss the Company's strategic initiatives, product pipeline and market opportunities.
Interested parties can access a live audio web cast of the presentation at www.halozyme.com. A replay of the presentation will be available for 14 days. To register for this conference or for additional information, visit www.rodmanandrenshaw.com.
About Halozyme Therapeutics, Inc.
Halozyme is a biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's portfolio of products under development is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme's recombinant human enzymes may replace current animal slaughterhouse-derived enzymes that carry potential risks of animal pathogen transmission and immunogenicity. The versatility of the first enzyme, rHuPH20, enables Halozyme to develop the product as a medical device, drug enhancement agent, and therapeutic biologic.
Halozyme Contact Investor Relations Contacts David A. Ramsay Don Markley / Zachary Bryant Chief Financial Officer Lippert/Heilshorn & Associates (858) 794-8889 (310) 691-7100 dramsay@halozyme.comdmarkley@lhai.com
Halozyme Therapeutics, Inc.CONTACT: David A. Ramsay, Chief Financial Officer of HalozymeTherapeutics, Inc., +1-858-794-8889, dramsay@halozyme.com; or InvestorRelations, Don Markley, dmarkley@lhai.com, or Zachary Bryant, both ofLippert/Heilshorn & Associates, +1-310-691-7100, for Halozyme Therapeutics,Inc.
Web site: http://www.halozyme.com/
